on Hong Kong Science And Technology Parks Corporation
HKSTP Showcases Innovation at BIO International Convention
On June 17, 2025, the Hong Kong Science and Technology Parks Corporation (HKSTP), alongside InvestHK, led 16 life and health tech firms to BIO 2025, the premier global biotechnology event in Boston. This marked the initial collaboration with the University of Hong Kong and Chinese University of Hong Kong medical faculties. The delegation aimed to highlight Hong Kong’s advancements in life sciences and health technologies, reinforcing its status as a biotech hub.
The HKSTP Pavilion featured diverse innovations, such as novel drug development and diagnostic technologies, attracting global industry attention. Notable achievements included Immuno Cure’s partnership with PharmaJet for needle-free vaccination solutions and a legal advisory pact with DLRC to enhance global collaboration.
CEO Albert Wong emphasized the importance of the collaboration for fostering innovation and solidifying Hong Kong’s role in life sciences. Additionally, HKSTP hosted networking events to connect Hong Kong companies with international investors and influencers in the field, driving sustainable growth in biotech development.
R. E.
Copyright © 2025 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all Hong Kong Science And Technology Parks Corporation news